The studies aim to improve early detection of chronic lung allograft dysfunction (CLAD), the leading cause of lung transplant failures.
Site Search
Showing 1 - 6 of 6 results
News
|
April 6, 2022
|
5 min read
News
|
Dec. 7, 2021
|
3 min read
Foundation to fund up to $110 million for collaboration to accelerate the development of genetic therapies for CF
News
|
Nov. 3, 2021
|
4 min read
The Cystic Fibrosis Lung Transplant Consortium Biorepository and Patient Registry, in collaboration with Cleveland Clinic, will provide critical clinical data and samples to support future research investigating complications of lung transplant.
News
|
Aug. 12, 2021
|
4 min read
Results show that people on Trikafta® enrolled in the six-week study were able to safely stop taking one of the two common CF medications without negatively affecting their health.
News
|
Nov. 4, 2022
|
4 min read
The Foundation and Bakar Labs will support AVECRIS Pte Ltd and Nosis Biological Sciences as they pursue genetic therapies for cystic fibrosis with their novel technologies.
News
|
July 21, 2022
|
4 min read